|
CCT4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.773600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.509400E-01 |
| Normal-vs-Stage2 |
3.069200E-01 |
| Normal-vs-Stage3 |
3.787800E-01 |
| Normal-vs-Stage4 |
3.970000E-01 |
| Stage1-vs-Stage2 |
4.599800E-01 |
| Stage1-vs-Stage3 |
6.785600E-01 |
| Stage1-vs-Stage4 |
6.840000E-01 |
| Stage2-vs-Stage3 |
6.730000E-01 |
| Stage2-vs-Stage4 |
7.710800E-01 |
| Stage3-vs-Stage4 |
9.254400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.767600E-01 |
| Normal-vs-AfricanAmerican |
1.449400E-01 |
| Normal-vs-Asian |
9.305000E-01 |
| Caucasian-vs-AfricanAmerican |
7.585800E-02 |
| Caucasian-vs-Asian |
5.692200E-01 |
| AfricanAmerican-vs-Asian |
1.810160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.211630E-01 |
| Normal-vs-Female |
6.230000E-01 |
| Male-vs-Female |
1.432380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.147000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.109800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.971190E-01 |
| Normal-vs-Age(81-100Yrs) |
4.984600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.214800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.120800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.440800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.121200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.493200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.971000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.251000E-01 |
| Classical-VS-Follicular |
7.969800E-04 |
| Classical-VS-Other |
6.358000E-01 |
| Classical-VS-Normal |
8.592200E-01 |
| Tall-VS-Follicular |
4.210100E-02 |
| Tall-VS-Other |
7.594600E-01 |
| Tall-VS-Normal |
7.108000E-01 |
| Follicular-VS-Other |
6.151400E-01 |
| Follicular-VS-Normal |
5.756500E-03 |
| Other-VS-Normal |
6.676800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.813800E-01 |
| Normal-vs-N1 |
1.170440E-02 |
| N0-vs-N1 |
5.062300E-02 |
|
|
